Ladogana, A.

disease patient protein creutzfeldt –jakob disease survival creutzfeldt-jakob disease 14-3-3 study level codon diagnosis cerebrospinal fl uid analysis table creutzfeldt-jakob sensitivity onset signi neurol creutzfeldt result neurology stage –jakob duration brain prion disease duration group mutation 14-3-3 test criteria health marker subtype codon 129 genotype fi ndings month nding number signi ficantly university department control codon 129 speci ficity flair scjd cases signi ficant cerebrospinal erasmus university rotterdam tau protein prion protein gene speci ficant fluence value genotype region signal surveillance gender concentration signi ficance cell count scjd patients count brain-derived proteins spongiform encephalopathies spongiform ficity imaging meissner sanchez-juan mri scans fication prion diseases 0.0 sequence ficantly